Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolution of heart transplantation.

C G McGregor1

  • 1Mayo Medical School, Rochester, Minnesota.

Cardiology Clinics
|February 1, 1990
PubMed
Summary

Heart transplantation evolved from animal research to a standard therapy for end-stage heart disease. Cyclosporine revolutionized the field, improving outcomes and paving the way for future innovations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A simple, safe, surgical technique for closing the persistent ductus arteriosus in the preterm neonate.

Annals of the Royal College of Surgeons of England·2009
Same author

Cardiac allograft remodeling after heart transplantation is associated with increased graft vasculopathy and mortality.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

Fatal disseminated aspergillosis following sequential heart and stem cell transplantation for systemic amyloidosis.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2002
Same author

Troponin levels in patients with amyloid cardiomyopathy undergoing cardiac transplantation.

The American journal of cardiology·2001
Same author

The effects of CTLA-4Ig on acute lung allograft rejection: a comparison of intrabronchial gene therapy with systemic administration of protein.

Transplantation·2001
Same author

Treatment of post-transplant lymphoproliferative disorder with monoclonal CD20 antibody (rituximab) after heart transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2001

Area of Science:

  • Cardiology
  • Surgical Innovation
  • Immunosuppression

Background:

  • Early heart transplantation efforts faced significant challenges.
  • The Stanford group's work in the 1970s validated heart transplantation as a viable therapy.
  • End-stage cardiac disease necessitated advanced treatment options.

Observation:

  • Preliminary animal experimentation laid the groundwork for human procedures.
  • Clinical attempts in the mid-20th century gradually improved success rates.
  • The widespread adoption of cyclosporine marked a turning point in immunosuppression.

Findings:

  • Heart transplantation transitioned from experimental to accepted medical practice by the 1980s.
  • Cyclosporine significantly enhanced graft survival and reduced rejection rates.
  • The success of heart transplantation spurred further research and development.

Implications:

  • Cyclosporine dramatically impacted global heart transplantation practices.
  • Future developments include advanced circulatory support systems and xenotransplantation.
  • Continued innovation promises to expand treatment options for cardiac patients.

Related Experiment Videos